HEADER LYASE 04-MAY-07 2PS6 TITLE N225D/S229T TRICHODIENE SYNTHASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRICHODIENE SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SESQUITERPENE CYCLASE, TS; COMPND 5 EC: 4.2.3.6; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FUSARIUM SPOROTRICHIOIDES; SOURCE 3 ORGANISM_TAXID: 5514; SOURCE 4 GENE: TRI5, TOX 5; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS TERPENOID SYNTHASE FOLD, SITE-DIRECTED MUTAGENESIS, NSE/DTE MOTIF, KEYWDS 2 MAGNESIUM, ETHYLENE GLYCOL, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR L.S.VEDULA,D.E.CANE,D.W.CHRISTIANSON REVDAT 6 30-AUG-23 2PS6 1 REMARK REVDAT 5 20-OCT-21 2PS6 1 REMARK SEQADV REVDAT 4 13-JUL-11 2PS6 1 VERSN REVDAT 3 24-FEB-09 2PS6 1 VERSN REVDAT 2 15-JAN-08 2PS6 1 JRNL REVDAT 1 18-DEC-07 2PS6 0 JRNL AUTH L.S.VEDULA,J.JIANG,T.ZAKHARIAN,D.E.CANE,D.W.CHRISTIANSON JRNL TITL STRUCTURAL AND MECHANISTIC ANALYSIS OF TRICHODIENE SYNTHASE JRNL TITL 2 USING SITE-DIRECTED MUTAGENESIS: PROBING THE CATALYTIC JRNL TITL 3 FUNCTION OF TYROSINE-295 AND THE JRNL TITL 4 ASPARAGINE-225/SERINE-229/GLUTAMATE-233-MG2+B MOTIF. JRNL REF ARCH.BIOCHEM.BIOPHYS. V. 469 184 2008 JRNL REFN ISSN 0003-9861 JRNL PMID 17996718 JRNL DOI 10.1016/J.ABB.2007.10.015 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 38757 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1940 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5829 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 8 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.44 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.800 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES WITH SIDE CHAIN B-FACTORS = REMARK 3 20.00 WERE REFINED AS ALANINES DUE TO DISORDER REMARK 4 REMARK 4 2PS6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042724. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91756 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38791 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 61.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.800 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.13300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.32500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1JFA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, SODIUM HEPES, CALCIUM REMARK 280 CHLORIDE, PH 6.9, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.05667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 100.11333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 100.11333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 50.05667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ARG A 355 REMARK 465 SER A 356 REMARK 465 LYS A 357 REMARK 465 ASP A 358 REMARK 465 VAL A 359 REMARK 465 LYS A 360 REMARK 465 GLU A 361 REMARK 465 VAL A 362 REMARK 465 GLN A 363 REMARK 465 LYS A 364 REMARK 465 PRO A 365 REMARK 465 PHE A 366 REMARK 465 LEU A 367 REMARK 465 SER A 368 REMARK 465 SER A 369 REMARK 465 ILE A 370 REMARK 465 GLU A 371 REMARK 465 LEU A 372 REMARK 465 VAL A 373 REMARK 465 GLU A 374 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ASN B 3 REMARK 465 PHE B 4 REMARK 465 ARG B 355 REMARK 465 SER B 356 REMARK 465 LYS B 357 REMARK 465 ASP B 358 REMARK 465 VAL B 359 REMARK 465 LYS B 360 REMARK 465 GLU B 361 REMARK 465 VAL B 362 REMARK 465 GLN B 363 REMARK 465 LYS B 364 REMARK 465 PRO B 365 REMARK 465 PHE B 366 REMARK 465 LEU B 367 REMARK 465 SER B 368 REMARK 465 SER B 369 REMARK 465 ILE B 370 REMARK 465 GLU B 371 REMARK 465 LEU B 372 REMARK 465 VAL B 373 REMARK 465 GLU B 374 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 78 48.70 -96.37 REMARK 500 TRP A 196 66.94 -119.61 REMARK 500 GLU A 252 60.63 60.43 REMARK 500 ASP A 281 129.94 -37.44 REMARK 500 ALA A 337 97.17 -57.71 REMARK 500 TRP A 343 -43.24 -146.49 REMARK 500 ARG B 23 -32.69 -134.54 REMARK 500 ASP B 24 -90.28 74.65 REMARK 500 SER B 25 25.29 49.75 REMARK 500 TYR B 27 165.49 52.69 REMARK 500 LYS B 57 96.23 -65.92 REMARK 500 TRP B 78 49.70 -98.25 REMARK 500 SER B 102 131.99 -27.45 REMARK 500 ASN B 167 55.44 33.91 REMARK 500 GLU B 233 -75.78 -76.77 REMARK 500 ASP B 235 -89.51 -38.16 REMARK 500 ASP B 236 54.54 -99.52 REMARK 500 ASP B 281 114.61 -35.63 REMARK 500 ARG B 304 -31.74 -32.99 REMARK 500 ARG B 306 43.18 31.50 REMARK 500 GLU B 309 8.35 -55.77 REMARK 500 GLU B 312 43.55 -79.77 REMARK 500 LYS B 313 8.66 -161.98 REMARK 500 VAL B 314 -0.84 -154.40 REMARK 500 LYS B 315 -9.98 -58.62 REMARK 500 THR B 319 -108.89 -131.39 REMARK 500 ALA B 322 -17.65 69.76 REMARK 500 TRP B 343 -38.55 -155.74 REMARK 500 ASN B 353 -110.50 -77.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JFA RELATED DB: PDB REMARK 900 TRICHODIENE SYNTHASE FROM FUSARIUM SPOROTRICHIOIDES REMARK 900 RELATED ID: 1KIY RELATED DB: PDB REMARK 900 D100E TRICHODIENE SYNTHASE REMARK 900 RELATED ID: 1YJ4 RELATED DB: PDB REMARK 900 Y305F TRICHODIENE SYNTHASE REMARK 900 RELATED ID: 2AEK RELATED DB: PDB REMARK 900 R304K TRICHODIENE SYNTHASE REMARK 900 RELATED ID: 2PS4 RELATED DB: PDB REMARK 900 N225D TRICHODIENE SYNTHASE REMARK 900 RELATED ID: 2PS7 RELATED DB: PDB REMARK 900 Y295F TRICHODIENE SYNTHASE DBREF 2PS6 A 1 374 UNP P13513 TRI5_FUSSP 1 374 DBREF 2PS6 B 1 374 UNP P13513 TRI5_FUSSP 1 374 SEQADV 2PS6 ASP A 225 UNP P13513 ASN 225 ENGINEERED MUTATION SEQADV 2PS6 THR A 229 UNP P13513 SER 229 ENGINEERED MUTATION SEQADV 2PS6 ASP B 225 UNP P13513 ASN 225 ENGINEERED MUTATION SEQADV 2PS6 THR B 229 UNP P13513 SER 229 ENGINEERED MUTATION SEQRES 1 A 374 MET GLU ASN PHE PRO THR GLU TYR PHE LEU ASN THR THR SEQRES 2 A 374 VAL ARG LEU LEU GLU TYR ILE ARG TYR ARG ASP SER ASN SEQRES 3 A 374 TYR THR ARG GLU GLU ARG ILE GLU ASN LEU HIS TYR ALA SEQRES 4 A 374 TYR ASN LYS ALA ALA HIS HIS PHE ALA GLN PRO ARG GLN SEQRES 5 A 374 GLN GLN LEU LEU LYS VAL ASP PRO LYS ARG LEU GLN ALA SEQRES 6 A 374 SER LEU GLN THR ILE VAL GLY MET VAL VAL TYR SER TRP SEQRES 7 A 374 ALA LYS VAL SER LYS GLU CYS MET ALA ASP LEU SER ILE SEQRES 8 A 374 HIS TYR THR TYR THR LEU VAL LEU ASP ASP SER LYS ASP SEQRES 9 A 374 ASP PRO TYR PRO THR MET VAL ASN TYR PHE ASP ASP LEU SEQRES 10 A 374 GLN ALA GLY ARG GLU GLN ALA HIS PRO TRP TRP ALA LEU SEQRES 11 A 374 VAL ASN GLU HIS PHE PRO ASN VAL LEU ARG HIS PHE GLY SEQRES 12 A 374 PRO PHE CYS SER LEU ASN LEU ILE ARG SER THR LEU ASP SEQRES 13 A 374 PHE PHE GLU GLY CYS TRP ILE GLU GLN TYR ASN PHE GLY SEQRES 14 A 374 GLY PHE PRO GLY SER HIS ASP TYR PRO GLN PHE LEU ARG SEQRES 15 A 374 ARG MET ASN GLY LEU GLY HIS CYS VAL GLY ALA SER LEU SEQRES 16 A 374 TRP PRO LYS GLU GLN PHE ASN GLU ARG SER LEU PHE LEU SEQRES 17 A 374 GLU ILE THR SER ALA ILE ALA GLN MET GLU ASN TRP MET SEQRES 18 A 374 VAL TRP VAL ASP ASP LEU MET THR PHE TYR LYS GLU PHE SEQRES 19 A 374 ASP ASP GLU ARG ASP GLN ILE SER LEU VAL LYS ASN TYR SEQRES 20 A 374 VAL VAL SER ASP GLU ILE SER LEU HIS GLU ALA LEU GLU SEQRES 21 A 374 LYS LEU THR GLN ASP THR LEU HIS SER SER LYS GLN MET SEQRES 22 A 374 VAL ALA VAL PHE SER ASP LYS ASP PRO GLN VAL MET ASP SEQRES 23 A 374 THR ILE GLU CYS PHE MET HIS GLY TYR VAL THR TRP HIS SEQRES 24 A 374 LEU CYS ASP ARG ARG TYR ARG LEU SER GLU ILE TYR GLU SEQRES 25 A 374 LYS VAL LYS GLU GLU LYS THR GLU ASP ALA GLN LYS PHE SEQRES 26 A 374 CYS LYS PHE TYR GLU GLN ALA ALA ASN VAL GLY ALA VAL SEQRES 27 A 374 SER PRO SER GLU TRP ALA TYR PRO PRO VAL ALA GLN LEU SEQRES 28 A 374 ALA ASN VAL ARG SER LYS ASP VAL LYS GLU VAL GLN LYS SEQRES 29 A 374 PRO PHE LEU SER SER ILE GLU LEU VAL GLU SEQRES 1 B 374 MET GLU ASN PHE PRO THR GLU TYR PHE LEU ASN THR THR SEQRES 2 B 374 VAL ARG LEU LEU GLU TYR ILE ARG TYR ARG ASP SER ASN SEQRES 3 B 374 TYR THR ARG GLU GLU ARG ILE GLU ASN LEU HIS TYR ALA SEQRES 4 B 374 TYR ASN LYS ALA ALA HIS HIS PHE ALA GLN PRO ARG GLN SEQRES 5 B 374 GLN GLN LEU LEU LYS VAL ASP PRO LYS ARG LEU GLN ALA SEQRES 6 B 374 SER LEU GLN THR ILE VAL GLY MET VAL VAL TYR SER TRP SEQRES 7 B 374 ALA LYS VAL SER LYS GLU CYS MET ALA ASP LEU SER ILE SEQRES 8 B 374 HIS TYR THR TYR THR LEU VAL LEU ASP ASP SER LYS ASP SEQRES 9 B 374 ASP PRO TYR PRO THR MET VAL ASN TYR PHE ASP ASP LEU SEQRES 10 B 374 GLN ALA GLY ARG GLU GLN ALA HIS PRO TRP TRP ALA LEU SEQRES 11 B 374 VAL ASN GLU HIS PHE PRO ASN VAL LEU ARG HIS PHE GLY SEQRES 12 B 374 PRO PHE CYS SER LEU ASN LEU ILE ARG SER THR LEU ASP SEQRES 13 B 374 PHE PHE GLU GLY CYS TRP ILE GLU GLN TYR ASN PHE GLY SEQRES 14 B 374 GLY PHE PRO GLY SER HIS ASP TYR PRO GLN PHE LEU ARG SEQRES 15 B 374 ARG MET ASN GLY LEU GLY HIS CYS VAL GLY ALA SER LEU SEQRES 16 B 374 TRP PRO LYS GLU GLN PHE ASN GLU ARG SER LEU PHE LEU SEQRES 17 B 374 GLU ILE THR SER ALA ILE ALA GLN MET GLU ASN TRP MET SEQRES 18 B 374 VAL TRP VAL ASP ASP LEU MET THR PHE TYR LYS GLU PHE SEQRES 19 B 374 ASP ASP GLU ARG ASP GLN ILE SER LEU VAL LYS ASN TYR SEQRES 20 B 374 VAL VAL SER ASP GLU ILE SER LEU HIS GLU ALA LEU GLU SEQRES 21 B 374 LYS LEU THR GLN ASP THR LEU HIS SER SER LYS GLN MET SEQRES 22 B 374 VAL ALA VAL PHE SER ASP LYS ASP PRO GLN VAL MET ASP SEQRES 23 B 374 THR ILE GLU CYS PHE MET HIS GLY TYR VAL THR TRP HIS SEQRES 24 B 374 LEU CYS ASP ARG ARG TYR ARG LEU SER GLU ILE TYR GLU SEQRES 25 B 374 LYS VAL LYS GLU GLU LYS THR GLU ASP ALA GLN LYS PHE SEQRES 26 B 374 CYS LYS PHE TYR GLU GLN ALA ALA ASN VAL GLY ALA VAL SEQRES 27 B 374 SER PRO SER GLU TRP ALA TYR PRO PRO VAL ALA GLN LEU SEQRES 28 B 374 ALA ASN VAL ARG SER LYS ASP VAL LYS GLU VAL GLN LYS SEQRES 29 B 374 PRO PHE LEU SER SER ILE GLU LEU VAL GLU HET EDO A 700 4 HET EDO B 701 4 HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 HOH *72(H2 O) HELIX 1 1 PRO A 5 ILE A 20 1 16 HELIX 2 2 THR A 28 ALA A 48 1 21 HELIX 3 3 GLN A 49 LEU A 56 1 8 HELIX 4 4 ASP A 59 TRP A 78 1 20 HELIX 5 5 SER A 82 LEU A 99 1 18 HELIX 6 6 ASP A 100 SER A 102 5 3 HELIX 7 7 PRO A 106 VAL A 111 1 6 HELIX 8 8 ASN A 112 GLY A 120 1 9 HELIX 9 9 HIS A 125 ARG A 140 1 16 HELIX 10 10 GLY A 143 GLN A 165 1 23 HELIX 11 11 ASP A 176 GLY A 186 1 11 HELIX 12 12 LEU A 187 LEU A 195 1 9 HELIX 13 13 LEU A 206 PHE A 230 1 25 HELIX 14 14 SER A 242 GLU A 252 1 11 HELIX 15 15 SER A 254 SER A 278 1 25 HELIX 16 16 ASP A 281 ASP A 302 1 22 HELIX 17 17 ARG A 303 ARG A 306 5 4 HELIX 18 18 LEU A 307 VAL A 314 1 8 HELIX 19 19 THR A 319 ALA A 337 1 19 HELIX 20 20 SER A 339 TRP A 343 5 5 HELIX 21 21 PRO A 347 VAL A 354 1 8 HELIX 22 22 GLU B 7 ILE B 20 1 14 HELIX 23 23 THR B 28 ALA B 48 1 21 HELIX 24 24 GLN B 49 LEU B 56 1 8 HELIX 25 25 ASP B 59 TRP B 78 1 20 HELIX 26 26 SER B 82 ASP B 100 1 19 HELIX 27 27 PRO B 106 VAL B 111 1 6 HELIX 28 28 ASN B 112 GLY B 120 1 9 HELIX 29 29 HIS B 125 PHE B 135 1 11 HELIX 30 30 PHE B 135 ARG B 140 1 6 HELIX 31 31 GLY B 143 GLN B 165 1 23 HELIX 32 32 ASP B 176 GLY B 186 1 11 HELIX 33 33 LEU B 187 LEU B 195 1 9 HELIX 34 34 LEU B 206 THR B 229 1 24 HELIX 35 35 THR B 229 ASP B 236 1 8 HELIX 36 36 SER B 242 GLU B 252 1 11 HELIX 37 37 SER B 254 SER B 278 1 25 HELIX 38 38 ASP B 281 ASP B 302 1 22 HELIX 39 39 ARG B 303 ARG B 306 5 4 HELIX 40 40 LEU B 307 GLU B 312 1 6 HELIX 41 41 LYS B 324 ALA B 337 1 14 HELIX 42 42 SER B 339 TRP B 343 5 5 HELIX 43 43 PRO B 347 ASN B 353 1 7 CISPEP 1 TYR A 345 PRO A 346 0 -0.45 CISPEP 2 TYR B 345 PRO B 346 0 -0.51 SITE 1 AC1 5 TYR A 113 TRP A 128 ASN A 132 PHE A 135 SITE 2 AC1 5 PHE B 114 SITE 1 AC2 5 PHE A 114 TYR B 113 TRP B 128 ASN B 132 SITE 2 AC2 5 PHE B 135 CRYST1 122.230 122.230 150.170 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008181 0.004723 0.000000 0.00000 SCALE2 0.000000 0.009447 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006659 0.00000